Fig. 4.

Purified peripheral blood eosinophils (0·4 × 10⁶/ml) from healthy subjects (n = 8) were incubated with PF from the CAPD-patient with PFE, both during and after remission of the disease, or PF from a bacterial peritonitis patient or a newly started patient, for 120 min at +37°C. RhIL-5 (10 ng/ml) was used as a control. Results are presented as the proportion of IL-5Rα positive eosinophils. Statistics are based on the comparison with the RPMI control and the comparison between during and after remission of PFE.